Lucid Diagnostics

In Brief This Week: Illumina, Thermo Fisher, Tempus, Bionano Genomics, Danaher, More

News items for the week of Aug. 14, 2023

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.

Lucid Diagnostics

In Brief This Week: Illumina, Thermo Fisher, Tempus, Bionano Genomics, Danaher, More

Compact Gene Editing Enzyme May Improve Success Rates of Gene Therapies

People in the News at Veracyte, Invitae, Mount Sinai, InterVenn Biosciences, Applied BioCode, More

New Products Posted to GenomeWeb: Qiagen, IDT, Revvity, Mission Bio, NRichDx, More

FDA Releases Proposed Rule for Oversight of Laboratory-Developed Tests

CStone Pharmaceuticals, Genetron Companion Diagnostic Receives NMPA Approval

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Small Study of Gene Editing to Treat Sickle Cell Disease

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing